Top Markets
#1 Purr Purr +55.52%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +49.56%
#4 Non-Playable Coin Non-Playable Coin +29.16%
#5 StonkBroker StonkBroker +28.75%
#6 ApeX ApeX +27.06%
#7 Kinetiq Kinetiq +24.33%
#8 Pudgy Penguins Pudgy Penguins +21.56%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +21.07%
#10 OriginTrail OriginTrail +20.87%
Coin of the day
Purr Purr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ArcticZymes Technologies ASA ArcticZymes Technologies ASA

ArcticZymes Technologies ASA

AZT
Rang in Aktien #21263
ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the... ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the development, production, and global sale of recombinant enzymes. These specialized enzymes are essential for a variety of applications, including molecular research, in vitro diagnostic testing, and processes within biomanufacturing. The company's diverse product lineup includes several key enzymatic solutions. For example, its salt active nuclease is instrumental in eliminating nucleic acids during the manufacturing of viral vectors, recombinant proteins, and other critical reagents. ArcticZymes also supplies shrimp alkaline phosphatase and accompanying kits, which are vital for purifying samples before both Sanger and next-generation sequencing. Another significant product is cod UNG, frequently utilized in viral and other molecular diagnostic assays, alongside double-strand specific DNases and their related kits, engineered for the efficient removal of double-stranded DNA. The firm's polymerases are designed to drive technological progress in life science, molecular diagnostics, NGS, and synthetic biology. Furthermore, it offers proteinase for applications in microbiological diagnostics and liquid biopsies, and ligases, which are crucial for connecting DNA and RNA fragments. ArcticZymes Technologies boasts a broad international presence, serving markets in Norway, Germany, Lithuania, Italy, various other European nations, the United States, and additional global territories. Founded in 1990, the enterprise was initially known as Biotec Pharmacon ASA until June 2020, when it officially rebranded to its current name. Its corporate headquarters are located in Tromsø, Norway.
Aktienkurs
$2.18
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$111.34M
Veränderung (1 Tag)
-4.15%
Veränderung (1 Jahr)
-25.43%
Land
NO
Handel ArcticZymes Technologies ASA (AZT)

Kategorie

Healthcare
Gewinn für ArcticZymes Technologies ASA (AZT)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von ArcticZymes Technologies ASA betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von ArcticZymes Technologies ASA von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH